Global Ablation Technologies Revenue Is About 2.79 Billion USD In 2017
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, global market of Ablation Technologies developed rapidly, with an average growth rate of 9.3%. In 2017, global revenue of Ablation Technologies is about 2.79 billion USD.
The ablation technologies market, by type is segmented into Radiofrequency, Laser/Light, Cryoablation, Microwave, Hydrothermal and others ablation technology. In 2017, Radiofrequency is the largest market share with 54.7%, The microwave ablation technology segment is estimated to grow at the highest CAGR during 2018 to 2023.
The market by application Cardiovascular Disease, Cancer, Ophthalmology, Pain Management, Gynecology, Orthopedic Treatment, and others. The cancer segment is expected to command a major share of the ablation technologies market in 2017 with the market share 45.4%.
North America is the largest consumption place, with a consumption market share nearly 41.7% in 2017. Following North America; Europe is the second largest consumption place with the consumption market share of 28.3% in 2017. Ablation Technologies market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
Market competition is intense. Medtronic, AtriCure, Dornier MedTech, Boston Scientific, AngioDynamics, etc. are the leaders of the industry. And there will be more demand in this industry and more companies enter into this industry.
As per statistics from the World Health Organization, almost 17 million deaths each year are associated with cardiovascular diseases, of which atrial defibrillation is a major disorder. Moreover, the incidence of atrial fibrillation increases with age, attacking almost 1 out of every 20 people aged 65 and above.
Further, according to WHO statistics, in 2012, above 14 million people across the world were reported to have developed new types of cancer, about 32 million people were reported to be living with different type of cancers and more than 8 million deaths were associated with cancer across the globe. As such, the consistent rise in the patient pool of cancer and cardiovascular diseases will lead to significant demand for ablation devices in the forthcoming years.